Debiopharm Innovation Fund invests in future patient care
Debiopharm Innovation Fund1 is the strategic investment fund of the Debiopharm Group.
We invest in young innovative companies in the following areas:
- Smart data (pilot or early commercial stage)
- Therapeutics (discovery and early development)
- Diagnostics (development stage)
with a focus on technologies related to Debiopharm Group’s therapeutic areas of interest, oncology and infectious disease.
If you have an investment opportunity that falls into one of these areas, please contact us.
1Debiopharm Innovation Fund is the new name for Debiopharm Diagnostics from 2017